Danaher Posts 4 Percent Rise in Q2 Revenue, Mid-single Digit Growth at AB Sciex on Strong 6500 Sales | GenomeWeb

Danaher this week reported a 4 percent year-over-year increase in revenues for the second quarter, with its Life Sciences and Diagnostics revenues rose nearly 6 percent.

The company's AB Sciex division, which houses its mass spectrometry business, was up in the mid-single digits year over year, with growth in the applied and clinical research markets, as well as the pharmaceutical market, offsetting a reduction in revenues from academic researchers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.